Repligen Corp. (RGEN)
169.97
+6.64
(+4.07%)
USD |
NASDAQ |
Jan 21, 16:00
170.00
+0.03
(+0.02%)
Pre-Market: 09:28
Repligen Price: 169.97 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enovis Corp. | 23.68 |
| Perspective Therapeutics, Inc. | 2.55 |
| InfuSystem Holdings, Inc. | 8.62 |
| Xtant Medical Holdings, Inc. | 0.63 |
| VolitionRX Ltd. | 0.2915 |
Price Related Metrics
| PE Ratio | 6587.98 |
| PS Ratio | 13.55 |
| Price to Book Value | 4.593 |
| Price to Free Cash Flow | 92.67 |
| Earnings Yield | 0.02% |
| Market Cap | 9.568B |
| Operating PE Ratio | 205.24 |
| Normalized PE Ratio | 283.09 |